Lauren Spendley MSN, AGNP BC, AOCN

Mrs. Spendley received her bachelor of science in nursing, graduating Magna Cum Laude, from the University of New Hampshire in Durham, New Hampshire. She received her master of science in nursing from the University of North Carolina in Chapel Hill, North Carolina. She is a certified Advanced Oncology Certified Nurse Practitioner and a certified Adult-Geriatric Nurse Practitioner through the American Nurses Credentialing Center.

Mrs. Spendley co-authored “Neurological toxicities associated with chimeric antigen receptor T-cell therapy” which was published in Brain and she co-authored “Anti-CD19 CAR T-cell Therapy for Adult Patients with Refractory Large B-Cell Lymphoma”, published in the Journal of the Advanced Practitioner in Oncology (JADPRO).

Mrs. Spendley has been an integral part in the development of the Immune Effector Cell Therapy Program at Dana-Farber Cancer Institute and has been the program manager since its inception in March 2017. She has aimed to ensure that clinicians, particularly nursing, have a strong knowledge base in recognition and management of CAR T cell-related toxicities and that the institution has proper processes in place to continue to provide safe, high-quality care to a growing volume of patients. The program has become nationally known by patients and fellow cancer centers.